Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice
Szymon Macioszek(Gdańsk Medical University), Michał J. Markuszewski(Gdańsk Medical University), Agnieszka Woźniak(VIB-KU Leuven Center for Cancer Biology), Tomasz Stokowy(University of Bergen), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Bram Boeckx(VIB-KU Leuven Center for Cancer Biology), Patrick Schöffski(KU Leuven), Danuta Dudzik(Gdańsk Medical University), Rafał Bartoszewski(University of Wrocław)
Cited by 6
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
|The Lancet Oncology|2014|1.2k
Comprehensive review of antimicrobial activities of plant flavonoids
|Phytochemistry Reviews|2018|1.2k